Related references
Note: Only part of the references are listed.Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study
Celestino Sardu et al.
DIABETES CARE (2019)
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
Fei Luo et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
Yechen Han et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
Sifan Chen et al.
CELL METABOLISM (2019)
Loss of Diurnal Oscillatory Rhythms in Gut Microbiota Correlates with Changes in Circulating Metabolites in Type 2 Diabetic db/db Mice
Eleni Beli et al.
NUTRIENTS (2019)
Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice
Wei-Kai Wu et al.
GUT (2019)
Trimethylamine N-Oxide, Circulating Endothelial Progenitor Cells, and Endothelial Function in Patients with Stable Angina
Ruey-Hsing Chou et al.
SCIENTIFIC REPORTS (2019)
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Paige V. Bauer et al.
CELL METABOLISM (2018)
A Bacterial Microcompartment Is Used for Choline Fermentation by Escherichia coli 536
Taylor Herring et al.
JOURNAL OF BACTERIOLOGY (2018)
Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide
G. Latkovskis et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential
Adam B. Roberts et al.
NATURE MEDICINE (2018)
Endothelial function and dysfunction: Impact of metformin
Asma Nafisa et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record
James H. Flory et al.
BMJ OPEN (2018)
Changes of Cell Biochemical States Are Revealed in Protein Homomeric Complex Dynamics
Bram Stynen et al.
CELL (2018)
Modulation of the gut microbiota by metformin improves metabolic profiles in aged obese mice
Heetae Lee et al.
GUT MICROBES (2018)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
Elevated Circulating Trimethylamine N-Oxide Levels Contribute to Endothelial Dysfunction in Aged Rats through Vascular Inflammation and Oxidative Stress
Tiejun Li et al.
FRONTIERS IN PHYSIOLOGY (2017)
Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
Mohammed A. I. Al-Obaide et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Metformin Improves Endothelial Function and Reduces Blood Pressure in Diabetic Spontaneously Hypertensive Rats Independent from Glycemia Control: Comparison to Vildagliptin
Mahdi Hamidi Shishavan et al.
SCIENTIFIC REPORTS (2017)
Metformin and the gastrointestinal tract
Laura J. McCreight et al.
DIABETOLOGIA (2016)
Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels
M. Dambrova et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2016)
Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance
Edgars Liepinsh et al.
PHARMACOLOGICAL RESEARCH (2016)
Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae
Gints Kalnins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Characterization and Detection of a Widely Distributed Gene Cluster That Predicts Anaerobic Choline Utilization by Human Gut Bacteria
Ana Martinez-del Campo et al.
MBIO (2015)
Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
Ji Miao et al.
NATURE COMMUNICATIONS (2015)
Characterization of Choline Trimethylamine-Lyase Expands the Chemistry of Glycyl Radical Enzymes
Smaranda Craciun et al.
ACS CHEMICAL BIOLOGY (2014)
γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Robert A. Koeth et al.
CELL METABOLISM (2014)
Comparison of seven methods for extraction of bacterial DNA from fecal and cecal samples of mice
Janina Ferrand et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2014)
Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation
Janis Kuka et al.
LIFE SCIENCES (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study
Michael Lever et al.
PLOS ONE (2014)
Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice
Bart J. M. Eskens et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Meldonium Decreases the Diet-Increased Plasma Levels of Trimethylamine N-Oxide, a Metabolite Associated With Atherosclerosis
Maija Dambrova et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
Jian Ye et al.
BMC BIOINFORMATICS (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Metabonomic study of biochemical changes in the serum of type 2 diabetes mellitus patients after the treatment of metformin hydrochloride
Taoguang Huo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase
John S. Sack et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2008)
Metformin and the intestine
C. J. Bailey et al.
DIABETOLOGIA (2008)
Mechanisms underlying saturable intestinal absorption of metformin
William R. Proctor et al.
DRUG METABOLISM AND DISPOSITION (2008)
Share Paper
